I really wish that I could share your optimism.
Did you notice that Recce has not published any animal test results since March?
The last results included no experimental data, a departure from the past.
According to published intentions, they will submit their IND application any day now.
Where is all of the experimental data to support this application?
GIven their last 4C , they must be almost out of money.
The Lind funding arrangement covering about 20% of their monthly spend.
Suspect some big problems encountered during testing, otherwise they would have remained on schedule and we would have seen the expected results.
Logic dictates a significant capital raising is just around the corner.
You may well learn to expect a lot less from Recce, and sadly they seem to be well ahead of the downward curve.
I'd say things are moving glacially toward IND and cascading towards administration.
As a share holder I hope that my preceding comments are proved wrong.
Come on Recce. Tell your share holders what is happening.
RCE Price at posting:
19.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)